This site is intended for healthcare professionals
News

Phase III EORTC1325/KEYNOTE-054 trial of Keytruda meets secondary endpoint in melanoma.- Merck Inc

Read time: 1 mins
Last updated:28th Jun 2021
Published:20th Sep 2020
Condition: Metastatic Melanoma
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest